Rapid Molecular Flu Testing Platforms Revolutionize Influenza Diagnosis as Healthcare Systems Prioritize Faster, More Accurate Detection

https://researchintelo.com/rep....ort/rapid-molecular-

Seasonal influenza continues to pose a significant burden on global healthcare systems, driving demand for advanced diagnostic technologies that deliver rapid and reliable results. As healthcare providers increasingly emphasize early disease detection and effective infection control.

Rapid Molecular Flu Testing Platforms Market Research Report 2033
researchintelo.com

Rapid Molecular Flu Testing Platforms Market Research Report 2033

According to our latest research, the Global Rapid Molecular Flu Testing Platforms market size was valued at $2.1 billion in 2024 and is projected to reach $6.8 billion by 2033, expanding at a CAGR of 13.5% during 2024–2033.